A portfolio of essential medicines
Xyllomac®
Dosages and presentations
XYLLOMAC® 500 mg. Powder for solution for injection/infusion (I.M.-I.V.).
Box of 10 vials.
XYLLOMAC® 1g. Powder for solution for injection / infusion (I.M.-I.V.). Box of 10 vials. Box of 1 vial.
XYLLOMAC® 2g. Powder for solution for injection / infusion (IV). Box of 10 vials.
XYLLOMAC® 1g. Powder for solution for injection / infusion (I.M.-I.V.). Box of 10 vials. Box of 1 vial.
XYLLOMAC® 2g. Powder for solution for injection / infusion (IV). Box of 10 vials.
Product information - Patient information leaflet
Active ingredient
Amoxicillin
Marketing
- France
Product news
Product available
This information is intended for healthcare professionals.
Our therapeutic areas
and our main products
Infectiology & Pneumology
Amikacin
Aztreonam
Amoxicillin
Xyllomac®
(France)
Amoxicillin Delbert®
(Ireland)
Delamoxyle®
(Belgium - Luxembourg)
Delamoxyl®
(Switzerland)
Amoxicillin and clavulanic acid
Benzathine benzylpenicillin
Extencilline®
(France)
Extencin®
(Netherlands)
Benzylpenicillin benzathine
(United Kingdom)
N-acetylcysteine
Oxacillin
Istopen®
(France)
Penstapho®
(Italy)
Prostaphlin®
(Czech Republic)
Neurology
Lithium carbonate
Tropatépine hydrochloride
Pipotiazine palmitic ester
Lorazepam
Some of our products may be available internationally through our distributors, under different trade names. Please contact us to find out more.
REQUEST MEDICAL INFORMATION - REPORT AN ADVERSE EVENT
To request medical information on Delbert Pharma products or report an adverse event,
please write to pharmacovigilance@delbert.fr or contact us on + 33 1 46 99 68 20.